<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04736095</url>
  </required_header>
  <id_info>
    <org_study_id>3D</org_study_id>
    <nct_id>NCT04736095</nct_id>
  </id_info>
  <brief_title>3 Dimensional Ultrasound in Comparison to Hysteroscopy in Myomas</brief_title>
  <official_title>3 Dimensional Ultrasound in Comparison to Hysteroscopy in Diagnosis of Myomas</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aljazeera Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Aljazeera Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      • three-dimensional saline infusion sonohysterography (3D SIS) was performed in all cases. A&#xD;
      sterile Cuscoe speculum was passed, the cervix visualized and cleaned with sterile&#xD;
      chlorhexidine solution. A 3.3 mm soft plastic paediatric naso-gastric suction catheter was&#xD;
      then passed through the cervix into the uterine cavity without grasping the cervix.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The speculum was removed and a 5 MHz transvaginal 3D ultrasound probe inserted into the&#xD;
      vagina (Voluson 730; KretzTechnik, Austria).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 7, 2021</start_date>
  <completion_date type="Actual">May 17, 2021</completion_date>
  <primary_completion_date type="Actual">May 15, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The accuracy of 3D ultrasound in doiagnosis of submucous myomas in comparison to hysteroscopy</measure>
    <time_frame>one week</time_frame>
    <description>How many women will be diagnosed by 3D US to have submucous myoma</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">50</enrollment>
  <condition>Fibroid</condition>
  <arm_group>
    <arm_group_label>3D ultrasound for diagnosis of submucous myomas</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Hysteroscopy for diagnosis of submucous myoma</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>3D Ultrasound</intervention_name>
    <description>Doing 3D ultrasound for diagnosis of submucous myoma</description>
    <arm_group_label>3D ultrasound for diagnosis of submucous myomas</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Hysteroscopy</intervention_name>
    <description>Doing hysteroscopy for diagnosis of submucous myoma</description>
    <arm_group_label>Hysteroscopy for diagnosis of submucous myoma</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Women between 20 and 60 years with abnormal uterine bleeding&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  • Women between 20 and 60 years with abnormal uterine bleeding in form of heavy&#xD;
             menstrual bleeding, irregular and heavy menstrual bleeding) diagnosed on non-enhanced&#xD;
             two-dimensional ultrasonography with submucous fibroids.&#xD;
&#xD;
               -  Absence of STD, PID, active vaginal bleeding.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Presence of general cause of abnormal uterine bleeding&#xD;
&#xD;
               -  History of drug use that can cause vaginal bleeding (anticoagulants, OCPs, HRT)&#xD;
&#xD;
               -  History of recent hormonal treatment&#xD;
&#xD;
               -  High risk of undergoing hysteroscopy&#xD;
&#xD;
               -  Vaginal, Vulval causes of bleeding&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>women with submucous myomas</gender_description>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mahmoud Alalfy, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Algezeera hospitaland National Research Centre ,Egypt</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Algazeerah</name>
      <address>
        <city>Giza</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aljazeera( Al Gazeera) hospital</name>
      <address>
        <city>Giza</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>January 29, 2021</study_first_submitted>
  <study_first_submitted_qc>January 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 3, 2021</study_first_posted>
  <last_update_submitted>May 21, 2021</last_update_submitted>
  <last_update_submitted_qc>May 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leiomyoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

